Definately the hardest sell VCR have to achieve is the use of...

Definately the hardest sell VCR have to achieve is the use of LVAD's as a way to improve the lives of people suffering heart disease.
Every company developing this product have the same problem, acceptance.
The Ventrassist, when all trials are complete, will be the preferred device but it's all about the medical profession embracing the technology in bigger numbers.
When that happens then VCR's fortunes will escalate.
Yes, VCR is undervalued but no one believes in it.
This is why the directors put so much effort into papers and seminars, so they can spread the word and convert medical thought.
They need to show published results, and i mean results which make the medical community take notice.
This is why it's such a long road for ant LVAD company.
The technology is new and evolving and needs to be accepted.
VCR is crossing the t's and dotting the i's, it's the only way to achieve this.
I think due to the high cost of healthcare acceptance will happen, all it needs is first class survival rates in the trials and VCR will pay off.
And please don't bring up stem cell research, that's 10 to 15 years away.
LVAD's are the only options for the next 15 years.
They just have to prove themselves.